S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
NASDAQ:CNXC

Concentrix (CNXC) Stock Forecast, Price & News

$78.30
-1.99 (-2.48%)
(As of 10/3/2023 ET)
Compare
Today's Range
$77.86
$81.10
50-Day Range
$71.17
$88.11
52-Week Range
$70.58
$151.82
Volume
462,969 shs
Average Volume
368,447 shs
Market Capitalization
$4.08 billion
P/E Ratio
11.70
Dividend Yield
1.40%
Price Target
$120.60

Concentrix MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
54.0% Upside
$120.60 Price Target
Short Interest
Bearish
4.21% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.97
Upright™ Environmental Score
News Sentiment
0.27mentions of Concentrix in the last 14 days
Based on 16 Articles This Week
Insider Trading
Acquiring Shares
$58,319 Bought Last Quarter
Proj. Earnings Growth
8.69%
From $10.70 to $11.63 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.22 out of 5 stars

Business Services Sector

5th out of 314 stocks

Business Services, Not Elsewhere Classified Industry

2nd out of 91 stocks


CNXC stock logo

About Concentrix (NASDAQ:CNXC) Stock

Concentrix Corporation provides technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services. It also offers customer lifecycle management; customer experience/user experience strategy and design; analytics and actionable insights; digital transformation; and voice of the customer and analytics solutions. The company's clients include technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, healthcare, and others, as well as global IPOs, social brands, and banks. Concentrix Corporation was incorporated in 2009 and is based in Newark, California.

CNXC Price History

CNXC Stock News Headlines

Sneaky CEO Hides Monster AI Stock Under Secret Trade Name
The public isn't supposed to know about this monster AI stock under $5...It’s technology is quietly the engine that runs new powerful artificial intelligence models like ChatGPT. And Wall Street is getting hungry for more shares.
Concentrix Q3: Ticking The Right Boxes
Concentrix (CNXC) Receives a Buy from Scotiabank
Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer's
A small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer's, Parkinson's and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>>
Concentrix Concludes Merger With Webhelp
5 Best Affordable Tech Stocks To Buy Now
Concentrix Corporation: Is The Knife Still Falling
CNXC - Concentrix Corporation
The Latest Analyst Ratings for Concentrix
Concentrix prices $2.15B senior notes
See More Headlines
Receive CNXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Concentrix and its competitors with MarketBeat's FREE daily newsletter.

CNXC Company Calendar

Last Earnings
6/28/2023
Ex-Dividend for 8/8 Dividend
7/27/2023
Dividend Payable
8/08/2023
Today
10/03/2023
Ex-Dividend for 11/7 Dividend
10/26/2023
Dividend Payable
11/07/2023
Fiscal Year End
11/30/2023
Next Earnings (Estimated)
1/18/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:CNXC
Fax
N/A
Employees
315,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$120.60
High Stock Price Forecast
$165.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+54.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Net Income
$435.05 million
Pretax Margin
7.57%

Debt

Sales & Book Value

Annual Sales
$6.32 billion
Cash Flow
$16.88 per share
Book Value
$52.18 per share

Miscellaneous

Free Float
51,597,000
Market Cap
$4.08 billion
Optionable
Not Optionable
Beta
0.40
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Christopher A. Caldwell (Age 50)
    Pres, CEO & Director
    Comp: $2.66M
  • Mr. Andre S. ValentineMr. Andre S. Valentine (Age 60)
    Chief Financial Officer
    Comp: $1.2M
  • Mr. Richard RossoMr. Richard Rosso (Age 60)
    Exec. VP of Global Sales & Account Management
    Comp: $1.19M
  • Ms. Jane C. FogartyMs. Jane C. Fogarty (Age 56)
    Exec. VP of Legal & Corp. Sec.
    Comp: $684.94k
  • Mr. Cormac J. TwomeyMr. Cormac J. Twomey (Age 53)
    Exec. VP of Global Operations & Delivery
    Comp: $952.49k
  • Ms. Winnie Sun
    Sr. VP of Operations & Delivery
  • Mr. David E. Stein
    VP of Investor Relations
  • Ms. Debbie Gonzalez
    Sr. VP of Global Marketing & Communications
  • Mr. Jason Marasigan
    Sr. VP of Corp. Devel.
  • Ms. Diane Hanson
    Sr. VP of People Solutions













CNXC Stock - Frequently Asked Questions

Should I buy or sell Concentrix stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Concentrix in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNXC shares.
View CNXC analyst ratings
or view top-rated stocks.

What is Concentrix's stock price forecast for 2023?

5 equities research analysts have issued 1-year price targets for Concentrix's stock. Their CNXC share price forecasts range from $70.00 to $165.00. On average, they expect the company's stock price to reach $120.60 in the next twelve months. This suggests a possible upside of 54.0% from the stock's current price.
View analysts price targets for CNXC
or view top-rated stocks among Wall Street analysts.

How have CNXC shares performed in 2023?

Concentrix's stock was trading at $133.16 at the beginning of 2023. Since then, CNXC shares have decreased by 41.2% and is now trading at $78.30.
View the best growth stocks for 2023 here
.

Are investors shorting Concentrix?

Concentrix saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,820,000 shares, an increase of 7.1% from the August 31st total of 1,700,000 shares. Based on an average trading volume of 404,600 shares, the days-to-cover ratio is presently 4.5 days. Currently, 4.2% of the company's shares are short sold.
View Concentrix's Short Interest
.

When is Concentrix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, January 18th 2024.
View our CNXC earnings forecast
.

How were Concentrix's earnings last quarter?

Concentrix Co. (NASDAQ:CNXC) posted its quarterly earnings data on Wednesday, June, 28th. The company reported $2.69 earnings per share for the quarter, missing analysts' consensus estimates of $2.75 by $0.06. The firm earned $1.61 billion during the quarter, compared to analyst estimates of $1.66 billion. Concentrix had a trailing twelve-month return on equity of 19.04% and a net margin of 5.35%. The business's quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.74 earnings per share.

How often does Concentrix pay dividends? What is the dividend yield for Concentrix?

Concentrix declared a quarterly dividend on Wednesday, September 27th. Stockholders of record on Friday, October 27th will be paid a dividend of $0.303 per share on Tuesday, November 7th. This represents a $1.21 annualized dividend and a yield of 1.55%. The ex-dividend date is Thursday, October 26th. This is an increase from the stock's previous quarterly dividend of $0.28.
Read our dividend analysis for CNXC
.

Is Concentrix a good dividend stock?

Concentrix (NASDAQ:CNXC) pays an annual dividend of $1.10 per share and currently has a dividend yield of 1.37%. The dividend payout ratio is 16.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNXC will have a dividend payout ratio of 9.46% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNXC.

What guidance has Concentrix issued on next quarter's earnings?

Concentrix issued an update on its fourth quarter 2023 earnings guidance on Wednesday, September, 27th. The company provided earnings per share (EPS) guidance of $3.03-$3.15 for the period, compared to the consensus EPS estimate of $3.32. The company issued revenue guidance of $2.19 billion-$2.21 billion, compared to the consensus revenue estimate of $1.70 billion.

When did Concentrix IPO?

(CNXC) raised $75 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 5,000,000 shares at a price of $15.00 per share. BofA Merrill Lynch, Wells Fargo Securities, Citigroup, Jefferies, Scotia Howard Weil, Credit Suisse, J.P. Morgan, Evercore ISI, BB&T Capital Markets, Goldman, Sachs, The Huntington Investment Company, Stifel and Nomura acted as the underwriters for the IPO and Clarksons Platou Securities, Cowen and Company and Tuohy Brothers were co-managers.

What is Concentrix's stock symbol?

Concentrix trades on the NASDAQ under the ticker symbol "CNXC."

How do I buy shares of Concentrix?

Shares of CNXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Concentrix's stock price today?

One share of CNXC stock can currently be purchased for approximately $78.30.

How much money does Concentrix make?

Concentrix (NASDAQ:CNXC) has a market capitalization of $4.08 billion and generates $6.32 billion in revenue each year. The company earns $435.05 million in net income (profit) each year or $6.69 on an earnings per share basis.

How many employees does Concentrix have?

The company employs 315,000 workers across the globe.

How can I contact Concentrix?

The official website for the company is www.concentrix.com. The company can be reached via phone at 800-747-0583 or via email at david.stein@concentrix.com.

This page (NASDAQ:CNXC) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -